Biodesix, Inc.
BDSX
$0.2867
-$0.0132-4.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.42M | -42.93M | -43.82M | -44.51M | -47.06M |
| Total Depreciation and Amortization | 5.79M | 5.77M | 5.63M | 5.38M | 5.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.17M | 10.18M | 10.42M | 12.36M | 12.45M |
| Change in Net Operating Assets | -15.48M | -21.67M | -29.06M | -23.23M | -1.27M |
| Cash from Operations | -41.94M | -48.65M | -56.84M | -50.00M | -30.50M |
| Capital Expenditure | -3.07M | -3.23M | -5.38M | -10.99M | -15.48M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -234.00K | -210.00K | -182.00K | -168.00K | -152.00K |
| Cash from Investing | -3.30M | -3.44M | -5.56M | -11.15M | -15.63M |
| Total Debt Issued | -- | -- | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -45.00K | -51.00K | -51.00K | -50.00K | -50.00K |
| Issuance of Common Stock | 55.68M | 56.28M | 69.08M | 84.27M | 29.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.28M | -4.17M | -5.07M | -8.25M | -6.95M |
| Cash from Financing | 51.36M | 52.05M | 73.96M | 85.97M | 32.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.11M | -39.00K | 11.57M | 24.81M | -13.78M |